Invention Grant
- Patent Title: 3-substituted-4-pyrimidone derivatives
- Patent Title (中): 3-取代-4-嘧啶酮衍生物
-
Application No.: US10538766Application Date: 2003-12-12
-
Publication No.: US07683069B2Publication Date: 2010-03-23
- Inventor: Yoshihiro Usui , Masahiro Okuyama , Tokushi Hanano
- Applicant: Yoshihiro Usui , Masahiro Okuyama , Tokushi Hanano
- Applicant Address: JP Osaka FR Paris
- Assignee: Mitsubishi Tanabe Pharma Corporation,Sanofi-Aventis
- Current Assignee: Mitsubishi Tanabe Pharma Corporation,Sanofi-Aventis
- Current Assignee Address: JP Osaka FR Paris
- Agency: Greenblum & Bernstein, P.L.C.
- Priority: JP2002-383300 20021216; JP2002-383301 20021216
- International Application: PCT/JP03/15968 WO 20031212
- International Announcement: WO2004/055007 WO 20040701
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/505

Abstract:
A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof useful as a tau protein kinase 1 inhibitor: wherein X represents CH or nitrogen atom; R1 represents a C?1#191-C?12#191 alkyl group which may be substituted; R2 represents a C?1#191-C?8#191 alkyl group which may be substituted, a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 hetero atoms selected from the group consisting of oxygen atom, sulfur atom, and nitrogen atom, and having 5 to 10 ring-constituting atoms in total.
Public/Granted literature
- US20070142409A1 3-Substituted-4-pyrimidone derivatives Public/Granted day:2007-06-21
Information query